fda aod9604 approval status AOD-9604 Clinical Trial Results & (2026) Deep Dive: Regulatory Status of

This phase includes 1000 mcg (1 mg) injections daily for the first week

Initial correction of significant deficiency typically involves weekly or biweekly injections for several weeks until levels normalize and symptoms resolve

Neuropathy/Nerve Support: Prevents and treats nerve pain, numbness, and neurological complications

I am so glad I did this for myself and my health

The compound shows follicle-stimulating activity in cell culture and animal models, but zero published clinical trials have demonstrated efficacy in androgenetic alopecia or any other hair loss condition using subcutaneous AHK-Cu injection

However, it is essential to distinguish between the known biological roles of each ingredient and the unproven claim that injecting them together produces clinically meaningful fat loss